Will GYN Surgical Power Hologic's Growth in the Upcoming Q1 Earnings?

HOLX's GYN Surgical unit, boosted by MyoSure, Fluent and Gynesonics, drives 10.2% revenue growth and is likely to lift ...
Nasdaq

Hologic's GYN Surgical Dominance: What's Powering the Road Ahead?

The growing prevalence of gynecological diseases and increasing government investments to improve women’s health are fueling the demand for gynecology surgical instruments. According to Zion Market ...
The Globe and Mail

Hologic's GYN Surgical Segment Looks Poised for Long-Term Growth

The global Gynecological Devices market is expanding, supported by the higher prevalence of diseases like PCOS, uterine fibroids and cervical cancer, continued innovation in minimally invasive ...
Nasdaq

Hologic (HOLX) to Expand Surgical Portfolio With Bolder Buyout

Hologic, Inc. HOLX recently signed a definitive agreement to acquire Bolder Surgical for a deal value of nearly $160 million, subject to working capital and other customary closing adjustments. The ...